Morse Asset Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
7,596
-5,386
-41% -$2.35M 0.5% 49
2026
Q1
$5.98M Buy
12,982
+70
+0.5% +$35.4K 1.24% 21
2025
Q4
$7.31M Buy
12,912
+78
+0.6% +$41.5K 1.46% 16
2025
Q3
$5.74M Sell
12,834
-1,619
-11% -$777K 1.15% 24
2025
Q2
$7.85M Sell
14,453
-335
-2% -$175K 1.72% 13
2025
Q1
$7.32M Sell
14,788
-1,924
-12% -$1.06M 1.85% 15
2024
Q4
$8.72M Sell
16,712
-109
-0.6% -$56.8K 1.99% 12
2024
Q3
$8.26M Sell
16,821
-281
-2% -$131K 1.78% 14
2024
Q2
$7.61M Sell
17,102
-350
-2% -$139K 1.85% 16
2024
Q1
$6.96M Buy
17,452
+412
+2% +$156K 1.78% 16
2023
Q4
$5.75M Buy
17,040
+310
+2% +$92.4K 1.69% 17
2023
Q3
$4.89M Sell
16,730
-46
-0.3% -$14.4K 1.55% 20
2023
Q2
$5.74M Buy
16,776
+613
+4% +$185K 1.74% 15
2023
Q1
$4.13M Buy
16,163
+697
+5% +$172K 1.4% 24
2022
Q4
$4.1M Buy
15,466
+497
+3% +$121K 1.49% 17
2022
Q3
$2.81M Sell
14,969
-90
-0.6% -$19.3K 1.06% 26
2022
Q2
$3.02M Sell
15,059
-190
-1% -$44.6K 0.97% 29
2022
Q1
$4.6M Sell
15,249
-1,694
-10% -$495K 1.14% 26
2021
Q4
$6.09M Buy
16,943
+224
+1% +$77.1K 1.36% 20
2021
Q3
$5.54M Buy
16,719
+303
+2% +$102K 1.32% 19
2021
Q2
$5.03M Sell
16,416
-15
-0.1% -$4.21K 1.22% 21
2021
Q1
$4.05M Buy
16,431
+261
+2% +$65.7K 1.04% 26
2020
Q4
$4.41M Buy
16,170
+285
+2% +$70.8K 1.22% 23
2020
Q3
$3.76M Buy
15,885
+1,116
+8% +$251K 1.2% 21
2020
Q2
$2.81M Buy
14,769
+375
+3% +$67.2K 1% 29
2020
Q1
$2.38M Buy
14,394
+144
+1% +$26.4K 1.13% 24
2019
Q4
$2.81M Buy
14,250
+9,198
+182% +$1.72M 0.96% 30
2019
Q3
$909K Sell
5,052
-1,725
-25% -$298K 0.34% 68
2019
Q2
$1.19M Buy
6,777
+1,185
+21% +$203K 0.35% 70
2019
Q1
$1.06M Buy
5,592
+3,885
+228% +$690K 0.32% 69
2018
Q4
$273K Buy
1,707
+12
+0.7% +$2.03K 0.1% 102
2018
Q3
$324K Buy
1,695
+30
+2% +$5.33K 0.09% 109
2018
Q2
$266K Buy
+1,665
New +$254K 0.07% 123

Other funds holding ISRG

Morse Asset Management's ISRG Position: Q2 2026 in Review

Morse Asset Management reduced its Intuitive Surgical (ISRG) stake by 41% in Q2 2026, selling an estimated $2.35M and leaving 7,596 shares worth $3.02M. The position accounts for 0.5% of the portfolio, ranked #49.

Morse Asset Management first reported a position in ISRG in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.72M in Q4 2024. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Morse Asset Management held 7,596 shares of Intuitive Surgical worth $3.02M as of Q2 2026.
  • Morse Asset Management sold 5,386 Intuitive Surgical shares in Q2 2026, an estimated $2.35M.
  • Intuitive Surgical made up 0.5% of Morse Asset Management's portfolio in Q2 2026, its #49 holding.
  • Morse Asset Management first reported a position in Intuitive Surgical in Q2 2018 and has held it in 33 quarters since.
  • Morse Asset Management's Intuitive Surgical position peaked at $8.72M in Q4 2024.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.